SYNGLUTRA 10/1000


Extended release tablets
scheduling status
S4
registration number
53/21.2/0652
What SYNGLUTRA 10/1000 contains
Dapagliflozin (as dapagliflozin propanediol) and Metformin hydrochloride.
other ingredients
Carboxymethylcellulose sodium, Copovidone, Crospovidone, Ferric oxide yellow (E172), Hypromellose, Magnesium stearate, Mannitol, Microcrystalline cellulose, Silicon dioxide, Opadry II 85F94245 Pink film coating (Iron oxide red (E172), Macrogol (E1521), Part hydrolysed polyvinyl alcohol (E1203), Talc (E553b), Titanium dioxide (E171).
Therapeutic classification
A10BD15.
© 2026 SAHPRA. ALL RIGHTS RESERVED